Skip to content
2000
Volume 13, Issue 2
  • ISSN: 1874-4672
  • E-ISSN: 1874-4702

Abstract

One of the most common neurological disorders, which occurs among 1% of the population worldwide, is epilepsy. Therapeutic failure is common with epilepsy and nearly about 30% of patients fall in this category. Seizure suppression should not be the only goal while treating epilepsy but associated comorbidities, which can further worsen the condition, should also be considered. Treatment of such comorbidities such as depression, anxiety, cognition, attention deficit hyperactivity disorder and, various other disorders which co-exist with epilepsy or are caused due to epilepsy should also be treated. Novel targets or the existing targets are needed to be explored for the dual mechanism which can suppress both the disease and the comorbidity. New therapeutic targets such as IDO, nNOS, PAR1, NF-Κb are being explored for their role in epilepsy and various comorbidities. This review explores recent therapeutic targets for the treatment of comorbidities associated with epilepsy.

Loading

Article metrics loading...

/content/journals/cmp/10.2174/1874467212666191203101606
2020-05-01
2025-05-20
Loading full text...

Full text loading...

/content/journals/cmp/10.2174/1874467212666191203101606
Loading

  • Article Type:
    Review Article
Keyword(s): anxiety; cognition; comorbidities; depression; Epilepsy; therapeutic targets
This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error
Please enter a valid_number test